WS06 – 1 – Navigating Ancillary Management Challenges

This interactive discussion will cover topics such as:

– Identify important considerations for ensuring compatibility of IMP with common infusion materials & how they impact delivery of drug to the patient
– Identify key stakeholders (e.g. CMC, Clinical, CRO, CMO) involved in the process & how they may be leveraged to support the process
– Discuss how to develop a plan to ensure availability & continuity of compatible ancillaries across all regions within which the trials will be conducted
– Poll group & review pros & cons of different organizational approaches to management & delivery of ancillary supplies